Anti N-methyl-d-aspartate (NMDA) receptor encephalitis in children is associated with psychiatric changes, seizures, and dyskinesias. We present the first report of autistic regression in a toddler caused by this entity. A 33-month-old boy presented with decreased appetite, irritability, and insomnia following an upper respiratory tract infection. Over the next few weeks he lost language and social skills, and abnormal movements of his hand developed. Within a month, this patient came to fit the diagnostic criteria for autistic spectrum disorder. Upon investigation, anti-NMDA receptor antibodies were found in the boy's cerebrospinal fluid. He was treated with intravenous immunoglobulins and steroids, resulting in reacquisition of language and social skills and resolution of movements. Our case emphasizes the significance of suspecting anti-NMDA receptor encephalitis as the cause of autistic regression, even in an age group where the diagnosis of autistic spectrum disorder is typically made, and especially when presentation follows a febrile illness.
VitalianiRMasonWAncesB. Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol. 2005;58:594–604.
2.
DalmauJTüzünEWuHY. Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61:25.
3.
ShimazakiHAndoYNakanoIDalmauJ. Reversible limbic encephalitis with antibodies against the membranes of neurones of the hippocampus. J Neurol Neurosurg Psychiatry. 2007;78:324.
4.
IizukaTSakaiFIdeT. Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology. 2008;70:504.
5.
SekiMSuzukiSIizukaT. Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis. J Neurol Neurosurg Psychiatry. 2008;79:324.
6.
DalmauJGleichmanAJHughesEG. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7:1091.
7.
DalmauJLancasterEMartinez-HernandezE. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011;10:63.
8.
FloranceNRDavisRLLamC. Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol. 2009;66:11.
9.
Florance-RyanNDalmauJ. Update on anti-N-methyl-d-aspartate receptor encephalitis in children and adolescents. Curr Opin Pediatr. 2010;22:739.
10.
PeriniPCalabreseMRanzatoFTiberioMGalloP. Cerebrospinal fluid examination in the differential diagnosis of inflammatory myelopathies. Neurol Sci. 2001;22(suppl 2):S65–S68.
11.
LourencoPShiraniASaeediJOgerJSchreiberWETremlettH. Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression. Mult Scler. 2013;19:577–584.
12.
WeiYCLiuCHLinJJ. Rapid progression and brain atrophy in anti-AMPA receptor encephalitis. J Neuroimmunol. 2013;261:129–133.
13.
SansingLHTüzünEKoMWBacconJLynchDRDalmauJ. A patient with encephalitis associated with NMDA receptor antibodies. Nat Clin Pract Neurol. 2007;3:291–296.
American Psychiatric Association. Pervasive developmental disorders. In: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR®). Washington, DC: American Psychiatric Association; 2000:70
16.
OzonoffSIosifAMYoungGS. Onset patterns in autism: correspondence between home video and parent report. J Am Acad Child Adolesc Psychiatry. 2011;50:796.
17.
TuchmanRFRapinI. Regression in pervasive developmental disorders: seizures and epileptiform electroencephalogram correlates. Pediatrics. 1997;99:560.
18.
WernerEDawsonG. Validation of the phenomenon of autistic regression using home videotapes. Arch Gen Psychiatry. 2005;62:889.
19.
SinghVK. Phenotypic expression of autoimmune autistic disorder (AAD): a major subset of autism. Ann Clin Psychiatry. 2009;21:148–161.
20.
KeilADanielsJLForssenU. Parental autoimmune diseases associated with autism spectrum disorders in offspring. Epidemiology. 2010;21:805–808.
21.
JungJYKohaneISWallDP. Identification of autoimmune gene signatures in autism. Transl Psychiatry. 2011;1:e63.
22.
MolloyCAMorrowALMeinzen-DerrJ. Familial autoimmune thyroid disease as a risk factor for regression in children with autism spectrum disorder: a CPEA Study. J Autism Dev Disord. 2006;36:317–324.
23.
ComiAMZimmermanAWFryeVHLawPAPeedenJN. Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J Child Neurol. 1999;14:388–394.
24.
van GentTHeijnenCJTreffersPD. Autism and the immune system. J Child Psychol Psychiatry. 1997;38:337–349.
25.
CookEHJrPerryBDDawsonGWainwrightMSLeventhalBL. Receptor inhibition by immunoglobulins: specific inhibition by autistic children, their relatives, and control subjects. J Autism Dev Disord. 1993;23:67–78.
26.
SinghVKWarrenRAverettRGhaziuddinM. Circulating autoantibodies to neuronal and glial filament proteins in autism. Pediatr Neurol. 1997;17:88–90.
27.
ToddRDHickokJMAndersonGMCohenDJ. Antibrain antibodies in infantile autism. Biol Psychiatry. 1988;23:644–647.
28.
ConnollyAMChezMGPestronkA. Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders. J Pediatr. 1999;134:607–613.
29.
SinghVKRivasWH. Prevalence of serum antibodies to caudate nucleus in autistic children. Neurosci Lett. 2004;355:53–56.
30.
PlioplysAVGreavesAYoshidaW. Anti-CNS antibodies in childhood neurologic diseases. Neuropediatrics. 1989;20:93–102.
31.
BurgdorfJMoskalJRBrudzynskiSMPankseppJ. Rats selectively bred for low levels of play-induced 50 kHz vocalizations as a model for autism spectrum disorders: a role for NMDA receptors. Behav Brain Res. 2013;251:18–24.
32.
BurketJAHerndonALWinebargerEEJacomeLFDeutschSI. Complex effects of mGluR5 antagonism on sociability and stereotypic behaviors in mice: possible implications for the pharmacotherapy of autism spectrum disorders. Brain Res Bull. 2011;86:152–158.
33.
DeutschSIPepeGJBurketJA. d-Cycloserine improves sociability and spontaneous stereotypic behaviors in 4-week old mice. Brain Res. 2012;1439:96–107.
34.
AronsMHThynneCJGrabruckerAM. Autism-associated mutations in ProSAP2/Shank3 impair synaptic transmission and neurexin-neuroligin-mediated transsynaptic signaling. J Neurosci. 2012;32:14966–14978.
35.
BlundellJBlaissCAEthertonMR. Neuroligin-1 deletion results in impaired spatial memory and increased repetitive behavior. J Neurosci. 2010;30:2115–2129.
36.
WonHLeeHRGeeHY. Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function. Nature. 2012;486:261–265.
37.
EthertonMFöldyCSharmaM. Autism-linked neuroligin-3 R451C mutation differentially alters hippocampal and cortical synaptic function. Proc Natl Acad Sci U S A. 2011;108:13764–13769.
38.
MoskalJRBurgdorfJKroesRABrudzynskiSMPankseppJ.A novel NMDA receptor glycine-site partial agonist, GLYX-13, has therapeutic potential for the treatment of autism. Neurosci Biobehav Rev. 2011;35:1982–1988.
39.
NinanI. Oxytocin suppresses basal glutamatergic transmission but facilitates activity-dependent synaptic potentiation in the medial prefrontal cortex. J Neurochem. 2011;119:324–331.
40.
AnagnostouESooryaLChaplinW. Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial. Mol Autism. 2012;3:16.
